NEW YORK (GenomeWeb) – The field of personalized medicine has been suffering from a credibility problem. More than a decade after the completion of the Human Genome Project, some are disappointed at the limited number of new life-extending treatments that have resulted from the nearly $3 billion effort. The stewards of the HGP had overpromised what could be gleaned from the human biological blueprint, critics have said, wondering where all the cures are.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.

Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.

In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.

The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.